Barriers to completing colonoscopy after a positive fecal occult blood test
- PMID: 33573698
- PMCID: PMC7879608
- DOI: 10.1186/s13584-021-00444-2
Barriers to completing colonoscopy after a positive fecal occult blood test
Abstract
Background: Colorectal cancer leads to significant morbidity and mortality. Early detection and treatment are essential. Screening using fecal occult blood tests has increased significantly, but adherence to colonoscopy follow-up is suboptimal, increasing CRC mortality risk. The aim of this study was to identify barriers to colonoscopy following a positive FOBT at the level of the patient, physician, organization and policymakers.
Methods: This mixed methods study was conducted at two health care organizations in Israel. The study included retrospective analyses of 45,281 50-74 year-old members with positive fecal immunochemical tests from 2010 to 2014, and a survey of 772 patients with a positive test during 2015, with and without follow-up. The qualitative part of the study included focus groups with primary physicians and gastroenterologists and in-depth interviews with opinion leaders in healthcare.
Results: Patient lack of comprehension regarding the test was the strongest predictor of non-adherence to follow-up. Older age, Arab ethnicity, and lower socio economic status significantly reduced adherence. We found no correlation with gender, marital status, patient activation, waiting time for appointments or distance from gastroenterology clinics. Primary care physicians underestimate non-adherence rates. They feel responsible for patient follow-up, but express lack of time and skills that will allow them to ensure adherence among their patients. Gastroenterologists do not consider fecal occult blood an effective tool for CRC detection, and believe that all patients should undergo colonoscopy. Opinion leaders in the healthcare field do not prioritize the issue of follow-up after a positive screening test for colorectal cancer, although they understand the importance.
Conclusions: We identified important barriers that need to be addressed to improve the effectiveness of the screening program. Targeted interventions for populations at risk for non-adherence, specifically for those with low literacy levels, and better explanation of the need for follow-up as a routine need to be set in place. Lack of agreement between screening recommendations and gastroenterologist opinion, and lack of awareness among healthcare authority figures negatively impact the screening program need to be addressed at the organizational and national level.
Trial registration: This study was approved by the IRB in both participating organizations (Meuhedet Health Care Institutional Review Board #02-2-5-15, Maccabi Healthcare Institutional Review Board BBI-0025-16). Participant consent was waived by both IRB's.
Keywords: Adherence; Cancer; Colonoscopy; Positive colorectal cancer screening.
Conflict of interest statement
None of the authors have competing interests.
Figures

Similar articles
-
Is the patient activation measure associated with adherence to colonoscopy after a positive fecal occult blood test result?Isr J Health Policy Res. 2018 Dec 21;7(1):74. doi: 10.1186/s13584-018-0270-8. Isr J Health Policy Res. 2018. PMID: 30577883 Free PMC article. Clinical Trial.
-
Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1. Ont Health Technol Assess Ser. 2009. PMID: 23074514 Free PMC article.
-
Adherence to national guidelines for colorectal cancer screening in Israel: Comprehensive multi-year assessment based on electronic medical records.J Med Screen. 2021 Mar;28(1):25-33. doi: 10.1177/0969141320919152. Epub 2020 May 1. J Med Screen. 2021. PMID: 32356670
-
A Clinician's Guide to Fecal Occult Blood Testing for Colorectal Cancer.South Med J. 2016 Apr;109(4):248-55. doi: 10.14423/SMJ.0000000000000449. South Med J. 2016. PMID: 27043809 Review.
-
The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: A systematic review and meta-analysis.United European Gastroenterol J. 2019 Apr;7(3):424-448. doi: 10.1177/2050640619828185. Epub 2019 Feb 6. United European Gastroenterol J. 2019. PMID: 31019712 Free PMC article.
Cited by
-
Effect of Bowel Preparation to Colonoscopy Interval on Preparation Quality and Colonoscopy Outcomes: A Meta-Analysis.Turk J Gastroenterol. 2023 Jan;34(1):26-34. doi: 10.5152/tjg.2022.22033. Turk J Gastroenterol. 2023. PMID: 36511605 Free PMC article.
-
The impact of multi-target stool DNA testing in clinical practice in the United States: A real-world evidence retrospective study.Prev Med Rep. 2022 Nov 7;30:102045. doi: 10.1016/j.pmedr.2022.102045. eCollection 2022 Dec. Prev Med Rep. 2022. PMID: 36531100 Free PMC article.
-
Comorbidities and Risk Factors of Patients Diagnosed with CRC after Positive Fecal Test in Real Life.Cancers (Basel). 2022 Nov 12;14(22):5557. doi: 10.3390/cancers14225557. Cancers (Basel). 2022. PMID: 36428650 Free PMC article.
-
Barriers associated with inadequate follow-up of abnormal fecal immunochemical test results in a safety-net system: A mixed-methods analysis.Prev Med Rep. 2022 May 18;28:101831. doi: 10.1016/j.pmedr.2022.101831. eCollection 2022 Aug. Prev Med Rep. 2022. PMID: 35637893 Free PMC article.
References
-
- Anttila A, Lönnberg S, Ponti A, Suonio E, Villain P, Coebergh JW, von Karsa L. Towards better implementation of cancer screening in Europe through improved monitoring and evaluation and greater engagement of cancer registries. Eur J Cancer. 2015;51(9):1080–1081. doi: 10.1016/j.ejca.2015.05.001. - DOI - PubMed
-
- Colorectal Cancer: Screening, release date: June 2016 U.S. Preventive Task Force,. https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummar.... Accessed 20 February 2020.
-
- Hagoel L. Colorectal Cancer- early detection. 2012.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical